Treatment patterns and clinical outcomes for multiple myeloma in Korean patients: a database study
SCT eligibility and the reimbursement status of new drugs impact the treatment pattern of MM. Expanding access to new agents and identifying patients who can benefit from SCT are essential.
Authors
- Junghyun Yoon (ORCID: https://orcid.org/0000-0003-0356-6037)
- Jongheon Jung (ORCID: https://orcid.org/0000-0001-5886-0933)
- Boyoung Park (ORCID: https://orcid.org/0000-0003-1902-3184)
- Hyeon‐Seok Eom (ORCID: https://orcid.org/0000-0002-0484-2067)
- Y.S. Park
- Eunyoung Lee (ORCID: https://orcid.org/0000-0002-8463-7783)
- Soomin Yoon
Institutions
- National Cancer Center (KR)
- Hanyang University (KR)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1186/s12885-025-13615-0
- Citations
- 1
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.77